Soaring Demand Set to Propel Transfection Technologies Market to $1.85 Billion by 2029

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

What Is the Expected CAGR for the Transfection Technologies Market Through 2025?
In recent times, the market for transfection technologies has seen substantial growth. The growth forecasts predict an increase from $1.21 billion in 2024 to $1.32 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.2%. The notable expansion during the historical period can be traced back to the rising occurrence of chronic illnesses, wider usage of transfection technologies, escalating demand for cell and gene therapies, increased investment in research and development, and an uptick in cases of cancer.

What's the Projected Size of the Global Transfection Technologies Market by 2029?
In the coming years, it is anticipated that the transfection technologies market will see significant expansion, with its size projected to reach $1.85 billion by 2029, demonstrating a compound annual growth rate (CAGR) of 8.9%. This forthcoming growth can be credited to a surge in chronic and immunological diseases, an escalating requirement for cell-based therapies, a rising demand for protein production, increased investment and funding for drug delivery systems development, and a higher need for monoclonal antibodies. The forecast period will likely see certain trends, such as increased research and development in cell-based therapies, the use of more sophisticated transfection methods, greater demand for advanced therapeutic delivery systems, a rise in the use of dual-reporter assays and co-transfection experiments, and a heightened emphasis on personalized medicine.

View the full report here:
https://www.thebusinessresearchcompany.com/report/transfection-technologies-global-market-report

Top Growth Drivers in the Transfection Technologies Industry: What's Accelerating the Market?
The advancement of gene therapy is anticipated to boost the transfection technologies market's growth in the future. Gene therapy is an approach that seeks to cure or prevent diseases by altering genes, incorporating the insertion, repair, or replacement of defective genes. The surge in gene therapy is powered by advancements in genetic research, improved delivery methods, and its capacity to mitigate previously untreatable genetic disorders. Transfection technologies play a vital role in gene therapy as they enable the accurate, safe, and efficient transport of genetic matter into cells. These technologies aid both transient and permanent genome alterations, which are critical for addressing genetic illnesses and cancers. For example, As reported by the American Society of Gene & Cell Therapy (ASGCT), and Citeline, both US-based entities, there were 247 gene therapies in Phase II as of July 2023. This figure rose by 5%, hitting 260 by the close of the second quarter (Q2) in 2023. Consequently, the upswing in gene therapy is spurring the growth of the transfection technologies market.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19228&type=smp

What Trends Will Shape the Transfection Technologies Market Through 2029 and Beyond?
Significant players in the transfection technologies market are concentrating on the advancement of cutting-edge technology, such as mechanoporation transfection systems, to facilitate complex and personalized applications in research and therapeutic fields. Mechanoporation transfection systems employ mechanical force to form temporary openings in cell membranes, permitting the entry of genetic material into cells. This technique is both efficient and minimally invasive, ensuring better preservation of cell viability. For example, in July 2024, STEMCELL Technologies, a biotechnology firm based in Canada, introduced CellPore, a pioneering transfection system. The system comprises a benchtop unit and the CellPore Transfection Kit 300, supplied with a specialized reagent kit and single-use delivery cartridges. CellPore, utilizing controlled, swift deformation in microfluidic channels, successfully imparts small molecules, nucleic acids, proteins, and gene editing complexes into cells while causing minimal cell disruption and maintaining high viability. These characteristics are fundamental for propelling research and cultivating advanced cell and gene therapies.

What Are the Main Segments in the Transfection Technologies Market?
The transfection technologiesmarket covered in this report is segmented -

1) By Product: Kits And Reagents, Equipment, Other Products
2) By Transfection Method: Lipofection, Electroporation, Nucleofection, Cotransfection, Cationic Lipid Transfection, In-Vivo Transfection, Other Transfection Methods
3) By Application: Virus Production, Protein Production, Gene Silencing, Stem Cell Reprogramming And Differentiation, Stable Cell Line Generation, Therapeutic Delivery, Biomedical Research, Other Applications
4) By End-User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations (CROs) And Contract Development And Manufacturing Organizations (CDMOs), Academic And Research Institutes, Other End-Users

Subsegments:
1) By Kits And Reagents: Transfection Kits, RNAi Reagents, DNA Reagents, Protein Transfection Reagents
2) By Equipment: Electroporation Devices, Microinjection Equipment, Lipofection Devices, Sonoporation Equipment
3) By Other Products: Transfection Software, Transfection Consumables, Custom Transfection Solutions

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=19228&type=smp

Which Top Companies are Driving Growth in the Transfection Technologies Market?
Major companies operating in the transfection technologies market are Thermo Fisher Scientific Inc., Lonza Group Ltd., Agilent Technologies Inc., Sartorius AG, Revvity Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corp., STEMCELL Technologies Inc., Promega Corporation, Takara Bio Inc., OriGene Technologies Inc., Applied Biological Materials Inc., MaxCyte Inc., New England Biolabs Inc., Cell Signaling Technology Inc., System Biosciences LLC, AMSBIO LLC, Altogen Biosystems, OZ Biosciences, Biontex Laboratories GmbH, RJH Biosciences Inc.

Which Regions Will Dominate the Transfection Technologies Market Through 2029?
North America was the largest region in the transfection technologies market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the transfection technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=19228

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.